| GRP94 in ER quality control and stress responses D Eletto, D Dersh, Y Argon Seminars in cell & developmental biology 21 (5), 479-485, 2010 | 265 | 2010 |
| Protein disulfide isomerase A6 controls the decay of IRE1α signaling via disulfide-dependent association D Eletto, D Eletto, D Dersh, T Gidalevitz, Y Argon Molecular cell 53 (4), 562-576, 2014 | 253 | 2014 |
| A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion D Dersh, J Hollý, JW Yewdell Nature Reviews Immunology 21 (2), 116-128, 2021 | 182 | 2021 |
| Decoding mRNA translatability and stability from the 5′ UTR L Jia, Y Mao, Q Ji, D Dersh, JW Yewdell, SB Qian Nature Structural & Molecular Biology 27 (9), 814-821, 2020 | 134 | 2020 |
| Ribosomal proteins regulate MHC class I peptide generation for immunosurveillance J Wei, RJ Kishton, M Angel, CS Conn, N Dalla-Venezia, V Marcel, ... Molecular cell 73 (6), 1162-1173. e5, 2019 | 96 | 2019 |
| Genome-wide Screens Identify Lineage-and Tumor-Specific Genes Modulating MHC-I-and MHC-II-Restricted Immunosurveillance of Human Lymphomas D Dersh, JD Phelan, ME Gumina, B Wang, JH Arbuckle, J Holly, ... Immunity 54 (1), 116-131. e10, 2021 | 91 | 2021 |
| Stress and aging induce distinct polyQ protein aggregation states LEM Mazzeo, D Dersh, M Boccitto, RG Kalb, T Lamitina Proceedings of the National Academy of Sciences 109 (26), 10587-10592, 2012 | 71 | 2012 |
| Interferon inducible pseudouridine modification in human mRNA by quantitative nanopore profiling S Huang, W Zhang, CD Katanski, D Dersh, Q Dai, K Lolans, J Yewdell, ... Genome Biology 22 (1), 1-14, 2021 | 63 | 2021 |
| Tay–Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum–associated degradation D Dersh, Y Iwamoto, Y Argon Molecular biology of the cell 27 (24), 3813-3827, 2016 | 60 | 2016 |
| Peptide Channeling: The Key to MHC Class I Immunosurveillance? JW Yewdell, D Dersh, R Fåhraeus Trends in Cell Biology, 2019 | 49 | 2019 |
| Varied role of ubiquitylation in generating MHC class I peptide ligands J Wei, D Zanker, AR Di Carluccio, MG Smelkinson, K Takeda, ... The Journal of Immunology 198 (10), 3835-3845, 2017 | 48 | 2017 |
| Limitation of individual folding resources in the ER leads to outcomes distinct from the unfolded protein response D Eletto, A Maganty, D Eletto, D Dersh, C Makarewich, C Biswas, ... J Cell Sci 125 (20), 4865-4875, 2012 | 43 | 2012 |
| OS-9 facilitates turnover of nonnative GRP94 marked by hyperglycosylation D Dersh, SM Jones, D Eletto, JC Christianson, Y Argon Molecular biology of the cell 25 (15), 2220-2234, 2014 | 37 | 2014 |
| A SIINFEKL-based system to measure MHC class I antigen presentation efficiency and kinetics D Dersh, JW Yewdell, J Wei Antigen Processing: Methods and Protocols, 109-122, 2019 | 23 | 2019 |
| Immune MAL2-practice: breast cancer immunoevasion via MHC class I degradation D Dersh, JW Yewdell The Journal of Clinical Investigation 131 (1), 2021 | 15 | 2021 |
| Long interleukin-22 binding protein isoform-1 is an intracellular activator of the unfolded protein response P Gómez-Fernández, A Urtasun, AW Paton, JC Paton, F Borrego, D Dersh, ... Frontiers in immunology 9, 2934, 2018 | 15 | 2018 |
| I’ve got algorithm: predicting tumor and autoimmune peptide targets for CD8+ T cells D Dersh, JW Yewdell The Journal of clinical investigation 126 (12), 4399-4401, 2016 | 8 | 2016 |
| Author Correction: A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion D Dersh, J Hollý, JW Yewdell Nature Reviews Immunology 20 (10), 644-644, 2020 | 5 | 2020 |
| Preventing Parkinson’s pathology ME DeSantis, D Dersh Disease models & mechanisms 3 (7-8), 399-400, 2010 | 5 | 2010 |
| Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules GF Papadaki, O Ani, TJ Florio, MC Young, JN Danon, Y Sun, D Dersh, ... Frontiers in Immunology 14, 1116906, 2023 | 3 | 2023 |
